Search
Markets
News
Analysis
Tools
Stock Screener
Learn
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
nasdaq-phvs
/
Pharvaris NV
PHVS
Add to Watchlist
33.950
USD
-0.630
-1.82%
Close 07/01, 16:00(ET)
Quotes delayed by 15 min
34.580
USD
+34.580
After-hours 07/02, 17:00 (ET)
2.37B
Market Cap
Loss
P/E TTM
Pharvaris NV
33.950
-0.630
-1.82%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Thu, Feb 19
Updated: Thu, Feb 19
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
General Atlantic LLC
11.53%
Fidelity Management & Research Company LLC
9.19%
Foresite Capital Management, LLC
6.86%
VenBio Partners LLC
6.66%
Viking Global Investors LP
5.24%
Other
60.52%
Shareholders
Shareholders
Proportion
General Atlantic LLC
11.53%
Fidelity Management & Research Company LLC
9.19%
Foresite Capital Management, LLC
6.86%
VenBio Partners LLC
6.66%
Viking Global Investors LP
5.24%
Other
60.52%
Shareholder Types
Shareholders
Proportion
Private Equity
31.30%
Hedge Fund
20.13%
Investment Advisor
18.48%
Investment Advisor/Hedge Fund
10.17%
Venture Capital
4.94%
Individual Investor
4.89%
Research Firm
0.63%
Pension Fund
0.07%
Bank and Trust
0.07%
Other
9.33%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
165
59.26M
90.60%
-451.33K
2025Q4
152
61.74M
96.38%
+11.01M
2025Q3
118
49.64M
77.50%
-950.63K
2025Q2
125
52.21M
81.51%
-1.38M
2025Q1
125
53.89M
99.06%
+200.61K
2024Q4
123
53.45M
98.98%
+218.03K
2024Q3
114
53.86M
99.73%
+1.03M
2024Q2
83
52.08M
96.43%
-141.66K
2024Q1
76
49.63M
98.30%
-831.88K
2023Q4
69
47.76M
94.74%
+8.60M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
General Atlantic LLC
8.03M
12.54%
--
--
Dec 31, 2025
Fidelity Management & Research Company LLC
6.40M
9.99%
--
--
Dec 31, 2025
Foresite Capital Management, LLC
4.78M
7.46%
--
--
Dec 31, 2025
VenBio Partners LLC
4.64M
7.24%
--
--
Dec 31, 2025
Viking Global Investors LP
3.65M
5.7%
--
--
Dec 31, 2025
EQT Partners AB
3.42M
5.35%
--
--
Dec 31, 2025
Deerfield Management Company, L.P.
3.13M
4.88%
+683.58K
+27.99%
Dec 31, 2025
Bain Capital Life Sciences Investors, LLC
2.80M
4.37%
-379.19K
-11.92%
Dec 31, 2025
Wellington Management Company, LLP
1.91M
2.98%
+171.05K
+9.86%
Dec 31, 2025
Commodore Capital LP
1.89M
2.95%
-529.03K
-21.87%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Virtus LifeSci Biotech Clinical Trials ETF
0.87%
ALPS Medical Breakthroughs ETF
0.59%
iShares MSCI Netherlands ETF
0.23%
SPDR S&P International Small Cap ETF
0.08%
iShares MSCI Europe Small-Cap ETF
0.04%
iShares MSCI EAFE Small-Cap ETF
0.02%
Fidelity Nasdaq Composite Index ETF
0.01%
Xtrackers MSCI Eurozone Hedged Eqty ETF
0.01%
Avantis International Small Cap Equity ETF
0%
First Trust IPOX Europe Equity Opportunities ETF
0%
View more
Virtus LifeSci Biotech Clinical Trials ETF
Proportion
0.87%
ALPS Medical Breakthroughs ETF
Proportion
0.59%
iShares MSCI Netherlands ETF
Proportion
0.23%
SPDR S&P International Small Cap ETF
Proportion
0.08%
iShares MSCI Europe Small-Cap ETF
Proportion
0.04%
iShares MSCI EAFE Small-Cap ETF
Proportion
0.02%
Fidelity Nasdaq Composite Index ETF
Proportion
0.01%
Xtrackers MSCI Eurozone Hedged Eqty ETF
Proportion
0.01%
Avantis International Small Cap Equity ETF
Proportion
0%
First Trust IPOX Europe Equity Opportunities ETF
Proportion
0%